FDA Drug Application (050627) for RIFADIN by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number050627
Product Number001
FormINJECTABLE;INJECTION
Dosage600MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameRIFADIN
Active IngredientRIFAMPIN



Back to FDA Applications sponsored by SANOFI AVENTIS US

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.